Literature DB >> 8262521

von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis.

M Yao1, F Latif, M L Orcutt, I Kuzmin, T Stackhouse, F W Zhou, K Tory, F M Duh, F Richards, E Maher.   

Abstract

Von Hippel-Lindau disease (VHL) is an inherited multisystem neoplastic disorder. We prepared a 2.5-megabase (Mb) restriction map of the region surrounding the VHL gene and identified and characterized overlapping deletions in three unrelated patients affected with VHL. The smallest nested deletion (100 kb) was located within a 510-kb NruI fragment detected by 19-63'. The rearrangements detected will be useful in isolating and evaluating candidate cDNAs for the VHL gene. The detailed physical map will be useful in studying the organization and structure of genes in the VHL region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262521     DOI: 10.1007/bf00420947

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  Polymerase chain reaction (PCR) for detection of HindIII polymorphism at the D3F15S2 locus.

Authors:  P S Ganly; P H Rabbitts
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

2.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus.

Authors:  G M Glenn; L N Daniel; P Choyke; W M Linehan; E Oldfield; M B Gorin; S Hosoe; F Latif; G Weiss; M Walther
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

5.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

6.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

7.  Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis.

Authors:  E R Maher; E Bentley; J R Yates; D Barton; A Jennings; I W Fellows; M A Ponder; B A Ponder; C Benjamin; R Harris
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

8.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

9.  Confirmation of linkage in von Hippel-Lindau disease.

Authors:  J M Vance; K W Small; M A Jones; J M Stajich; L H Yamaoka; A D Roses; W Y Hung; M A Pericak-Vance
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

10.  von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region.

Authors:  F Latif; F M Duh; J Gnarra; K Tory; I Kuzmin; M Yao; T Stackhouse; W Modi; L Geil; L Schmidt
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

View more
  6 in total

Review 1.  The von Hippel-Lindau gene: turning discovery into therapy.

Authors:  Peter E Clark; Michael S Cookson
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Congenital anomalies and genetic disorders in families of children with central nervous system tumours.

Authors:  S M Jones; P C Phillips; P T Molloy; B J Lange; M N Needle; J A Biegel
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

3.  BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.

Authors:  Hisashi Hasumi; Mitsuko Furuya; Kenji Tatsuno; Shogo Yamamoto; Masaya Baba; Yukiko Hasumi; Yasuhiro Isono; Kae Suzuki; Ryosuke Jikuya; Shinji Otake; Kentaro Muraoka; Kimito Osaka; Narihiko Hayashi; Kazuhide Makiyama; Yasuhide Miyoshi; Keiichi Kondo; Noboru Nakaigawa; Takashi Kawahara; Koji Izumi; Junichi Teranishi; Yasushi Yumura; Hiroji Uemura; Yoji Nagashima; Adam R Metwalli; Laura S Schmidt; Hiroyuki Aburatani; W Marston Linehan; Masahiro Yao
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

4.  Playing Tag with HIF: The VHL Story.

Authors:  Sherri K. Leung; Michael Ohh
Journal:  J Biomed Biotechnol       Date:  2002

Review 5.  Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation.

Authors:  Hisashi Hasumi; Masahiro Yao
Journal:  Cancer Sci       Date:  2018-02-15       Impact factor: 6.716

6.  Comprehensive characterization of Alu-mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families.

Authors:  Cathy D Vocke; Christopher J Ricketts; Laura S Schmidt; Mark W Ball; Lindsay A Middelton; Berton Zbar; W Marston Linehan
Journal:  Hum Mutat       Date:  2021-03-19       Impact factor: 4.700

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.